Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-04-17 @ 12:17 AM
Study NCT ID:
NCT00500058
Status:
COMPLETED
Last Update Posted:
2017-07-26
First Post:
2007-07-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2010-03-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-10
First Submit QC Date:
None
Study First Post Date:
2007-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-24
Last Update Post Date:
2017-07-26
Last Update Post Date Type:
ACTUAL